Free Trial

Profound Medical (PROF) Competitors

Profound Medical logo
$5.64 -0.06 (-1.05%)
Closing price 03:59 PM Eastern
Extended Trading
$5.66 +0.03 (+0.44%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROF vs. SMLR, EMBC, CBLL, BVS, BBNX, AVNS, AXGN, KIDS, BFLY, and DCTH

Should you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include Semler Scientific (SMLR), Embecta (EMBC), CeriBell (CBLL), Bioventus (BVS), Beta Bionics (BBNX), Avanos Medical (AVNS), AxoGen (AXGN), OrthoPediatrics (KIDS), Butterfly Network (BFLY), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry.

Profound Medical vs. Its Competitors

Semler Scientific (NASDAQ:SMLR) and Profound Medical (NASDAQ:PROF) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

Semler Scientific has a net margin of -60.69% compared to Profound Medical's net margin of -269.35%. Semler Scientific's return on equity of 19.75% beat Profound Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Semler Scientific-60.69% 19.75% 15.47%
Profound Medical -269.35%-70.41%-57.22%

49.4% of Semler Scientific shares are held by institutional investors. Comparatively, 47.9% of Profound Medical shares are held by institutional investors. 30.2% of Semler Scientific shares are held by insiders. Comparatively, 1.5% of Profound Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Semler Scientific had 6 more articles in the media than Profound Medical. MarketBeat recorded 7 mentions for Semler Scientific and 1 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.94 beat Semler Scientific's score of 0.47 indicating that Profound Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Semler Scientific
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Profound Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Semler Scientific currently has a consensus price target of $89.00, suggesting a potential upside of 115.81%. Profound Medical has a consensus price target of $11.00, suggesting a potential upside of 95.04%. Given Semler Scientific's stronger consensus rating and higher possible upside, equities analysts plainly believe Semler Scientific is more favorable than Profound Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Semler Scientific
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
Profound Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Semler Scientific has higher revenue and earnings than Profound Medical. Semler Scientific is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Semler Scientific$56.29M10.03$40.90M-$2.61-15.80
Profound Medical$10.68M15.87-$27.82M-$1.22-4.62

Semler Scientific has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500.

Summary

Semler Scientific beats Profound Medical on 13 of the 16 factors compared between the two stocks.

Get Profound Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PROF vs. The Competition

MetricProfound MedicalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$171.15M$2.46B$5.54B$9.41B
Dividend YieldN/A1.80%3.75%4.03%
P/E RatioN/A4.4521.0120.09
Price / Sales15.87709.89433.8199.01
Price / CashN/A164.7736.1658.27
Price / Book2.815.008.125.65
Net Income-$27.82M$30.99M$3.25B$257.91M
7 Day Performance-2.93%1.69%0.97%2.09%
1 Month Performance-16.32%9.20%7.36%11.13%
1 Year Performance-43.54%-1.25%31.31%18.40%

Profound Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PROF
Profound Medical
2.6136 of 5 stars
$5.64
-1.1%
$11.00
+95.0%
-41.3%$171.15M$10.68M0.00150News Coverage
SMLR
Semler Scientific
2.6444 of 5 stars
$45.23
-0.7%
$89.00
+96.8%
+20.4%$619.20M$56.29M-17.33120
EMBC
Embecta
4.6723 of 5 stars
$10.37
-1.0%
$19.33
+86.4%
-27.6%$606.05M$1.08B11.522,100Analyst Forecast
CBLL
CeriBell
2.5445 of 5 stars
$16.38
+1.5%
$32.14
+96.2%
N/A$591.97M$65.44M0.00N/A
BVS
Bioventus
2.7778 of 5 stars
$6.81
-2.3%
$13.75
+101.9%
-9.4%$559.40M$567.70M-11.161,200
BBNX
Beta Bionics
N/A$12.83
+1.3%
$23.44
+82.7%
N/A$556.31M$65.12M0.00294Positive News
Gap Up
AVNS
Avanos Medical
2.893 of 5 stars
$11.85
-0.6%
N/A-48.6%$548.13M$687.80M-1.422,227News Coverage
AXGN
AxoGen
2.1753 of 5 stars
$12.02
+1.1%
$24.50
+103.8%
+22.7%$547.39M$187.34M-80.13450News Coverage
Analyst Revision
KIDS
OrthoPediatrics
4.1279 of 5 stars
$22.14
+1.1%
$35.83
+61.8%
-36.0%$537.78M$204.73M-12.65200
BFLY
Butterfly Network
2.3938 of 5 stars
$1.83
+0.8%
$3.50
+91.8%
+55.4%$451.30M$82.06M-6.29460News Coverage
DCTH
Delcath Systems
2.6137 of 5 stars
$11.87
+4.7%
$24.00
+102.2%
+44.8%$413.43M$37.21M-23.7460News Coverage
Positive News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:PROF) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners